<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Pershing Square Capital Management, L.P. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=23696></link><description><![CDATA[Pershing Square Capital Management, L.P. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Fri, 15 May 2026 02:26:52 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><language>ko-KR</language><item><title><![CDATA[Valeant, Allergan, and Pershing Square Have Agreed to Drop Lawsuit in Allergan v. Valeant Pharmaceuticals International]]></title><link>https://www.newswire.co.kr/newsRead.php?no=788466</link><description><![CDATA[NEW YORK--(Business Wire/Korea Newswire)--Regulatory News:  Pershing Square Capital Management, L.P. has confirmed that on April 9, 2015 the parties to the lawsuit entitled Allergan, Inc., et al. v. Valeant Pharmaceuticals International, Inc., et al., No. 14-1214 DOC (ANx) (C.D. Cal.) have executed and filed with the court a Joint Stipulation of Voluntary Dismissal, dismissing the actio...]]></description><pubDate>Fri, 10 Apr 2015 10:05:00 +0900</pubDate></item><item><title><![CDATA[밸리언트, 앨러간, 퍼싱 스퀘어- 앨러간, 밸리언트 파마슈티컬스 인터내셔널 간의 소송 취하 합의]]></title><link>https://www.newswire.co.kr/newsRead.php?no=788468</link><description><![CDATA[뉴욕--(Business Wire/뉴스와이어)--공시 뉴스:  퍼싱 스퀘어 캐피털 매니지먼트(Pershing Square Capital Management, L.P.)가 2015년 4월 9일 ‘앨러간(Allergan, Inc., et al) 대 밸리언트 파마슈티컬스 인터내셔널(Valeant Pharmaceuticals International, Inc., et al.), No. 14-1214 DOC (ANx) (C.D. Cal.)’ 소송 당사자들이 법원에 ‘소송취하 공동합의서(Joint Stipulation of Voluntary Dismissal)를 제...]]></description><pubDate>Fri, 10 Apr 2015 10:05:00 +0900</pubDate></item><item><title><![CDATA[Pershing Square To Make 13D Filing Disclosing 8.5% Stake In Zoetis]]></title><link>https://www.newswire.co.kr/newsRead.php?no=773502</link><description><![CDATA[NEW YORK--(Business Wire/Korea Newswire)--Pershing Square Capital Management, L.P. (PSCM) announced today that it intended to file a beneficial ownership report on schedule 13D with the United States Securities and Exchange Commission (SEC) to disclose its beneficial ownership of 41,823,145 shares of Zoetis, Inc. and additional economic exposure through cash-settled total return swaps r...]]></description><pubDate>Wed, 12 Nov 2014 16:35:00 +0900</pubDate></item><item><title><![CDATA[퍼싱 스퀘어, 조에티스 지분 8.5%를 공시하는 13D 보고서 제출 계획]]></title><link>https://www.newswire.co.kr/newsRead.php?no=773503</link><description><![CDATA[뉴욕--(Business Wire/뉴스와이어)--퍼싱 스퀘어 캐피털 매니지먼트(Pershing Square Capital Management, L.P.)(이하 PSCM)는 오늘 조에티스(Zoetis)에 보유한 자사의 수익소유권 지분 41,823,145주와 조에티스의 전체 주식 501,324,843주의 약 8.5% 지분에 대해 개념 주식 995,602주를 나타내는 현금 결제 총수익 스왑을 통한 추가 경제적 노출을 공시하기 위해 13D부칙에 관한 수익소유권 보고서를 미국증권...]]></description><pubDate>Wed, 12 Nov 2014 16:35:00 +0900</pubDate></item></channel></rss>